Literature DB >> 23743606

Aortic valve replacement in an elderly patient with factor XI deficiency.

Suguru Watanabe1, Tadanori Minagawa, Tomoaki Kagatani, Makoto Miura, Kouichi Tabayashi.   

Abstract

Factor XI (FXI) deficiency is rare and associated with bleeding after surgical procedures. We report a case of an 80-year-old woman with severe aortic valve stenosis. FXI deficiency was diagnosed due to prolonged activated partial thromboplastin time. Aortic valve replacement was performed using a porcine bioprosthetic valve. Intra-operation bleeding was controlled by the transfusion of a fresh frozen plasma. The postoperative course was uneventful.

Entities:  

Mesh:

Year:  2013        PMID: 23743606     DOI: 10.1007/s11748-013-0271-z

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

Review 1.  Antithrombotic therapy following bioprosthetic aortic valve replacement.

Authors:  Justin Nowell; Emma Wilton; Hugh Markus; Marjan Jahangiri
Journal:  Eur J Cardiothorac Surg       Date:  2007-01-30       Impact factor: 4.191

Review 2.  Pharmacologic tools to reduce bleeding in surgery.

Authors:  Sam Schulman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

3.  Cardiac surgery and catheterization in patients with haemophilia.

Authors:  N MacKinlay; J Taper; F Renisson; K Rickard
Journal:  Haemophilia       Date:  2000-03       Impact factor: 4.287

Review 4.  Factor XI deficiency and its management.

Authors:  P H Bolton-Maggs
Journal:  Haemophilia       Date:  2000-07       Impact factor: 4.287

Review 5.  Factor XI Deficiency.

Authors:  Stefano Duga; Ophira Salomon
Journal:  Semin Thromb Hemost       Date:  2009-07-13       Impact factor: 4.180

6.  Cardiovascular surgery in patients with congenital plasma coagulopathies.

Authors:  J C Vander Woude; J D Milam; W E Walker; D P Houchin; A P Weiland; D A Cooley
Journal:  Ann Thorac Surg       Date:  1988-09       Impact factor: 4.330

7.  Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.

Authors:  Tami Livnat; Ilia Tamarin; Yoram Mor; Harry Winckler; Zeev Horowitz; Yoseph Korianski; Barak Bar-Zakay; Uri Seligsohn; Ophira Salomon
Journal:  Thromb Haemost       Date:  2009-09       Impact factor: 5.249

Review 8.  Factor XI deficiency in humans.

Authors:  U Seligsohn
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

9.  Coronary artery bypass in hereditary factor XI deficiency.

Authors:  R Brunken; D Follette; J Wittig
Journal:  Ann Thorac Surg       Date:  1984-10       Impact factor: 4.330

  9 in total
  1 in total

1.  A Case Report of Severe Factor XI Deficiency during Cardiac Surgery: Less Can Be More.

Authors:  Toshinobu Kazui; Vance G Nielsen; Spencer D Audie; Rajagopalan M Venkataramani; John T Bryant; Kristin Swenson; Paul M Ford
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.